Kar

General Information


DRACP ID  DRACP04051

Peptide Name   Kar

Sequence  TTKKEELEKKKKT

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C69H127N19O23

Absent amino acids  ACDFGHIMNPQRSVWY

Common amino acids  K

Mass  180509

Pl  10.5

Basic residues  6

Acidic residues  3

Hydrophobic residues  1

Net charge  3

Boman Index  -5652

Hydrophobicity  -247.69

Aliphatic Index  30

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Two Novel Anticancer Peptides from Aurein 12

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16500

DRACP is developed by Dr.Zheng's team.